The global glucagon-like peptide-1 (GLP-1) agonists market reached a value of USD 19.70 Billion in 2024. With type 2 diabetes and obesity becoming increasingly prevalent worldwide, the demand for GLP-1 agonists continues to grow. The market is projected to expand at a CAGR of 10.20% from 2025 to 2034, aiming to reach a valuation of USD 52.03 Billion by the end of the forecast period. https://www.expertmarketresearch.com/reports/glucagon-like-peptide-1-glp-1-agonists-market